MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Study Id: NCT03053193
Start Date:
- End Date:
|
|
|
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Study Id: NCT06075953
Start Date:
- End Date:
|
|
- Ductal Carcinoma in Situ
- Breast Cancer
- Carcinoma
|
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
Study Id: NCT04488081
Start Date:
- End Date:
|
|
|
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
Study Id: NCT04821141
Start Date:
- End Date:
|
|
|
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
Study Id: NCT02620852
Start Date:
- End Date:
|
|
- Breast Cancer
- Cancer, General
|
Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)
Study Id: NCT02872025
Start Date:
- End Date:
|
|
- Carcinoma, Intraductal, Noninfiltrating
- Immunotherapy
- Carcinoma
|
Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast
Study Id: NCT00788112
Start Date:
- End Date:
|
|
|
Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery
Study Id: NCT00033397
Start Date:
- End Date:
|
|
|
Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer
Study Id: NCT00416403
Start Date:
- End Date:
|
|
|
Postoperative Pain Control With Fentanyl Patch in Patients Undergoing Mastectomy and TRAM or DIEP Flap Reconstruction
Study Id: NCT01258296
Start Date:
- End Date:
|
|
|
Study of Ductal Lavage in Women at High Risk for Breast Cancer
Study Id: NCT00429988
Start Date:
- End Date:
|
|
|
Statins and Breast Cancer Biomarkers
Study Id: NCT00914017
Start Date:
- End Date:
|
|
|
